Logo 1 Logo 2

Clinical Trial Details

Trial ID: L7361
Source ID: NCT00283751
Associated Drug: Insulin Detemir
Title: Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes|Diabetes Mellitus, Type 2
Interventions: DRUG: insulin detemir|DRUG: insulin glargine
Outcome Measures: Primary: HbA1c, after 52 weeks | Secondary: Insulin antibodies|Incident of hypoglycaemic episodes and adverse events|Plasma glucose profiles|Change in body weight
Sponsor/Collaborators: Sponsor: Novo Nordisk A/S
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 583
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2003-03
Completion Date: 2004-11
Results First Posted:
Last Update Posted: 2017-01-27
Locations: Novo Nordisk Investigational Site, Greenbrae, California, 94904, United States|Novo Nordisk Investigational Site, La Mesa, California, 91942, United States|Novo Nordisk Investigational Site, West Palm Beach, Florida, 33401, United States|Novo Nordisk Investigational Site, Atlanta, Georgia, 30318, United States|Novo Nordisk Investigational Site, Chicago, Illinois, 60607, United States|Novo Nordisk Investigational Site, Springfield, Illinois, 62711, United States|Novo Nordisk Investigational Site, Topeka, Kansas, 66606, United States|Novo Nordisk Investigational Site, Chesterfield, Missouri, 63017, United States|Novo Nordisk Investigational Site, St. Louis, Missouri, 63141, United States|Novo Nordisk Investigational Site, Lincoln, Nebraska, 68521, United States|Novo Nordisk Investigational Site, Pleasantville, New Jersey, 08232, United States|Novo Nordisk Investigational Site, Cleveland, Ohio, 44195, United States|Novo Nordisk Investigational Site, Kettering, Ohio, 45429, United States|Novo Nordisk Investigational Site, Philadelphia, Pennsylvania, 19140, United States|Novo Nordisk Investigational Site, Mt. Pleasant, South Carolina, 29464, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75230, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75246, United States|Novo Nordisk Investigational Site, Dallas, Texas, 75390-8858, United States|Novo Nordisk Investigational Site, San Antonio, Texas, 78229, United States|Novo Nordisk Investigational Site, Warrenton, Virginia, 20186, United States|Novo Nordisk Investigational Site, Seattle, Washington, 98105, United States|Novo Nordisk Investigational Site, Ebreichsdorf, 2483, Austria|Novo Nordisk Investigational Site, Gratwein, 8112, Austria|Novo Nordisk Investigational Site, Graz, 8036, Austria|Novo Nordisk Investigational Site, Neunkirchen, 2620, Austria|Novo Nordisk Investigational Site, Wien, 1030, Austria|Novo Nordisk Investigational Site, Wien, A 1160, Austria|Novo Nordisk Investigational Site, Wolfsberg, 9400, Austria|Novo Nordisk Investigational Site, Bonheiden, 2820, Belgium|Novo Nordisk Investigational Site, Brussels, 1090, Belgium|Novo Nordisk Investigational Site, Edegem, 2650, Belgium|Novo Nordisk Investigational Site, Gent, 9000, Belgium|Novo Nordisk Investigational Site, Leuven, 3000, Belgium|Novo Nordisk Investigational Site, Besancon, 25030, France|Novo Nordisk Investigational Site, Bondy, 93143, France|Novo Nordisk Investigational Site, Grenoble, 38043, France|Novo Nordisk Investigational Site, LA ROCHELLE cedex, 17019, France|Novo Nordisk Investigational Site, Lyon, 69437, France|Novo Nordisk Investigational Site, Nantes, 44093, France|Novo Nordisk Investigational Site, Narbonne, 11108, France|Novo Nordisk Investigational Site, Nimes, 30006, France|Novo Nordisk Investigational Site, Paris Cedex 10, 75475, France|Novo Nordisk Investigational Site, Paris, 75877, France|Novo Nordisk Investigational Site, Poitiers, 86000, France|Novo Nordisk Investigational Site, Strasbourg, 67091, France|Novo Nordisk Investigational Site, TOULOUSE cedex, 31054, France|Novo Nordisk Investigational Site, Bad Kreuznach, 55545, Germany|Novo Nordisk Investigational Site, Bad Mergentheim, 97980, Germany|Novo Nordisk Investigational Site, Bad Neuenahr-Ahrweiler, 53474, Germany|Novo Nordisk Investigational Site, Berlin, 13355, Germany|Novo Nordisk Investigational Site, Dresden, 01307, Germany|Novo Nordisk Investigational Site, Flensburg, 24939, Germany|Novo Nordisk Investigational Site, Frankfurt, 60590, Germany|Novo Nordisk Investigational Site, Freiburg, 79106, Germany|Novo Nordisk Investigational Site, Friedrichsthal, 66299, Germany|Novo Nordisk Investigational Site, Furth, 93437, Germany|Novo Nordisk Investigational Site, Genthin, 39307, Germany|Novo Nordisk Investigational Site, Giessen, 35390, Germany|Novo Nordisk Investigational Site, Hamburg, 20251, Germany|Novo Nordisk Investigational Site, Hamburg, 21073, Germany|Novo Nordisk Investigational Site, Hamburg, 22607, Germany|Novo Nordisk Investigational Site, Heidelberg, 69115, Germany|Novo Nordisk Investigational Site, Krefeld, 47798, Germany|Novo Nordisk Investigational Site, Ludwigshafen, 67059, Germany|Novo Nordisk Investigational Site, Marl, 45770, Germany|Novo Nordisk Investigational Site, München, 81925, Germany|Novo Nordisk Investigational Site, Neumünster, 24534, Germany|Novo Nordisk Investigational Site, Neuss, 41460, Germany|Novo Nordisk Investigational Site, Nürnberg, 90402, Germany|Novo Nordisk Investigational Site, Rehlingen-Siersburg, 66780, Germany|Novo Nordisk Investigational Site, Saarbrücken, 66121, Germany|Novo Nordisk Investigational Site, Schaafheim, 64850, Germany|Novo Nordisk Investigational Site, Schwabenheim, 55270, Germany|Novo Nordisk Investigational Site, Schwedt, 16303, Germany|Novo Nordisk Investigational Site, St. Ingbert, 66386, Germany|Novo Nordisk Investigational Site, Völklingen, 66333, Germany|Novo Nordisk Investigational Site, Würzburg, 97072, Germany|Novo Nordisk Investigational Site, Dublin, DUBLIN 8, Ireland|Novo Nordisk Investigational Site, Dublin, Ireland|Novo Nordisk Investigational Site, Ayr, KA6 6DX, United Kingdom|Novo Nordisk Investigational Site, Barnsley, S75 2EP, United Kingdom|Novo Nordisk Investigational Site, Bolton, BL1 4QS, United Kingdom|Novo Nordisk Investigational Site, Bradford, BD9 6RJ, United Kingdom|Novo Nordisk Investigational Site, Church Village, CF38 1AB, United Kingdom|Novo Nordisk Investigational Site, Cosham, PO6 3LY, United Kingdom|Novo Nordisk Investigational Site, Dundee, DD1 9SY, United Kingdom|Novo Nordisk Investigational Site, Glasgow, G42 9TY, United Kingdom|Novo Nordisk Investigational Site, Harrow, HA1 3UJ, United Kingdom|Novo Nordisk Investigational Site, Leicester, LE1 5WW, United Kingdom|Novo Nordisk Investigational Site, Leicester, LE5 4PW, United Kingdom|Novo Nordisk Investigational Site, Livingstone, EH54 6PP, United Kingdom|Novo Nordisk Investigational Site, London, SE5 9RS, United Kingdom|Novo Nordisk Investigational Site, Newcastle, NE7 7DN, United Kingdom|Novo Nordisk Investigational Site, Poole, BH15 2JB, United Kingdom|Novo Nordisk Investigational Site, Salford, M6 8HD, United Kingdom|Novo Nordisk Investigational Site, Swansea, SA6 6NL, United Kingdom
URL: https://clinicaltrials.gov/show/NCT00283751

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress